Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Pfister

Showing results (51-60 of 127) with videos related to

Pageof 13
Sort By:
Annales De Pathologie|September 27, 2012
[Retroperitoneal bronchogenic cyst]Nicolas Piton, Françoise Gobet, Claire Werquin, et al.
Anti-Cancer Drugs|December 1, 2016
Final results of the phase III URO-BCG 4 multicenter study: efficacy and tolerance of one-third dose BCG maintenance in nonmuscle invasive bladder cancerFrançois X Nouhaud, Jérome Rigaud, Fabien Saint, et al.
The French Journal of Urology|June 29, 2024
Clinical impact of an enhanced recovery protocol implementation for nephrectomy and radical prostatectomyLucie Vangheluwe, Mathilde Legeay, Louis Surlemont, et al.
Anticancer Research|April 13, 2016
Predictive Value of NRAMP1 and HGPX1 Gene Polymorphism for Maintenance BCG Response in Non-muscle-invasive Bladder CancerClaire Lenormand, Jérôme Couteau, François-Xavier Nouhaud, et al.
Surgery in Practice and Science|January 23, 2025
Impact of fecal diversion in Perineal Necrotizing Soft Tissue Infection on disease survival: A large retrospective studyVincent Mayoral, Dorothée Coquerel-Beghin, Jean-Nicolas Cornu, et al.
The Journal of Urology|March 7, 2006
Polymorphisms of the human NRAMP1 gene are associated with response to bacillus Calmette-Guerin immunotherapy for superficial bladder cancerMarc Decobert, Hélène Larue, Alain Bergeron, et al.
Presse Medicale (Paris, France : 1983)|March 5, 2013
[Diagnosis and management of severe adverse events occurring during BCG therapy for non-muscle invasive bladder cancer (NMIBC)]Yann Neuzillet, Morgan Rouprêt, Stéphane Larré, et al.
American Journal of Medical Genetics. Part A|September 14, 2006
Early-onset low-grade papillary carcinoma of the bladder associated with Apert syndrome and a germline FGFR2 mutation (Pro253Arg)Andréas Andreou, Aude Lamy, Valérie Layet, et al.
Anti-Cancer Drugs|October 13, 2025
Real-world treatment patterns and survival outcomes in patients with metastatic castration-resistant prostate cancer in France: lessons from the prospective OPALE studyJosephine Papet, Laetitia Augusto-Pelegrin, François Christy, et al.
Neurourology and Urodynamics|September 12, 2018
The maximum detrusor pressure as a predictive factor of success after sphincterotomy in detrusor-sphincter dyssynergiaAlexandre Hourié, Francois-Xavier Nouhaud, Maximilien Baron, et al.
Pageof 13

Showing results (51-60 of 127) with videos related to

Sort By:
Pageof 13
Annales De Pathologie|September 27, 2012
[Retroperitoneal bronchogenic cyst]Nicolas Piton, Françoise Gobet, Claire Werquin, et al.
Anti-Cancer Drugs|December 1, 2016
Final results of the phase III URO-BCG 4 multicenter study: efficacy and tolerance of one-third dose BCG maintenance in nonmuscle invasive bladder cancerFrançois X Nouhaud, Jérome Rigaud, Fabien Saint, et al.
The French Journal of Urology|June 29, 2024
Clinical impact of an enhanced recovery protocol implementation for nephrectomy and radical prostatectomyLucie Vangheluwe, Mathilde Legeay, Louis Surlemont, et al.
Anticancer Research|April 13, 2016
Predictive Value of NRAMP1 and HGPX1 Gene Polymorphism for Maintenance BCG Response in Non-muscle-invasive Bladder CancerClaire Lenormand, Jérôme Couteau, François-Xavier Nouhaud, et al.
Surgery in Practice and Science|January 23, 2025
Impact of fecal diversion in Perineal Necrotizing Soft Tissue Infection on disease survival: A large retrospective studyVincent Mayoral, Dorothée Coquerel-Beghin, Jean-Nicolas Cornu, et al.
The Journal of Urology|March 7, 2006
Polymorphisms of the human NRAMP1 gene are associated with response to bacillus Calmette-Guerin immunotherapy for superficial bladder cancerMarc Decobert, Hélène Larue, Alain Bergeron, et al.
Presse Medicale (Paris, France : 1983)|March 5, 2013
[Diagnosis and management of severe adverse events occurring during BCG therapy for non-muscle invasive bladder cancer (NMIBC)]Yann Neuzillet, Morgan Rouprêt, Stéphane Larré, et al.
American Journal of Medical Genetics. Part A|September 14, 2006
Early-onset low-grade papillary carcinoma of the bladder associated with Apert syndrome and a germline FGFR2 mutation (Pro253Arg)Andréas Andreou, Aude Lamy, Valérie Layet, et al.
Anti-Cancer Drugs|October 13, 2025
Real-world treatment patterns and survival outcomes in patients with metastatic castration-resistant prostate cancer in France: lessons from the prospective OPALE studyJosephine Papet, Laetitia Augusto-Pelegrin, François Christy, et al.
Neurourology and Urodynamics|September 12, 2018
The maximum detrusor pressure as a predictive factor of success after sphincterotomy in detrusor-sphincter dyssynergiaAlexandre Hourié, Francois-Xavier Nouhaud, Maximilien Baron, et al.
Pageof 13